• Publications
  • Influence
Use and timing of surfactant administration: impact on neonatal outcomes in extremely low gestational age infants born in Canadian Neonatal Intensive Care Units
Abstract Background: Use, timing and doses of surfactant in preterm infants are variable in practice in modern NICUs. Objective: The objective of this study is to explore the association between useExpand
  • 6
  • 2
Transient hyperaldosteronism and neonatal hypertension: Case series and literature review
Neonatal hypertension is an uncommon but important problem in Neonatal Intensive Care Unit. The most common cause of neonatal hypertension is renovascular disease. In premature neonates, hypertensionExpand
  • 3
  • 2
Prospective study of fluconazole therapy in systemic neonatal fungal infection.
BACKGROUND Standard neonatal systemic antifungal therapy with amphotericin B and flucytosine can be associated with toxicity, drug resistance and the need for prolonged venous access. There isExpand
  • 57
  • 1
Impact of oxygen concentration on time to resolution of spontaneous pneumothorax in term infants: a population based cohort study
BackgroundLittle evidence exists regarding the optimal concentration of oxygen to use in the treatment of term neonates with spontaneous pneumothorax (SP). The practice of using high oxygenExpand
  • 13
  • 1
Stimulated case recall interviews applied to a national protocol for hyperbilirubinemia
National guidelines for the investigation of hyperbilirubinemia (jaundice in the newborn) and management by phototherapy were developed and widely disseminated in Canada. Adoption of the protocol atExpand
  • 9
  • 1
Comparison of low and high sodium and potassium content in oral rehydration solutions.
Oral rehydration solutions (ORS) with low and high sodium or potassium contents were compared in 84 infants aged 3-15 months with dehydration caused by acute watery diarrhea. In randomized,Expand
  • 61
Severe Congenital Chylothorax Treated With Octreotide
We report a neonate with severe congenital chylothorax. Subcutaneous octreotide was added to the standard treatment regime. The chylothorax resolved with no observed side effects.
  • 34
Extended interval dosing of gentamicin in premature neonates ≤ 28‐week gestation
Aim:  To evaluate an extended interval dosing (EID) regimen of gentamicin in neonates ≤28‐week gestation.
  • 18
Validation of a Dosage Individualization Table for Extended-Interval Gentamicin in Neonates
BACKGROUND: Extended-interval aminoglycoside dosing is increasingly used in neonates; however, guidance on how to monitor concentrations and adjust dosages accordingly is limited. OBJECTIVE: ToExpand
  • 9